<DOC>
	<DOC>NCT01109017</DOC>
	<brief_summary>This study is conducted in Japan. The aim of this observational study is to collect information about the safety and efficacy of Norditropin® long-term treatment of growth hormone deficiency in adults.</brief_summary>
	<brief_title>Observational Study of the Safety and Efficacy of Norditropin® in Adult Patients With Growth Hormone Deficiency</brief_title>
	<detailed_description />
	<mesh_term>Endocrine System Diseases</mesh_term>
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<criteria>Severe adult growth hormone deficiency Known or suspected allergy to study product(s) or related products Previous participation in the study Diabetes Mellitus Presence of malignant tumor(s) Pregnant or likely to get pregnant</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
</DOC>